Use of Botox as diagnostic model for migraine headache has positive predictive value of 89.5%. HealthDay News — Diagnostic targeted Botox injections have high positive predictive value for migraine ...

Please provide your email address to receive an email when new articles are posted on . The study included 58 young persons with migraine flares lasting 24 hours to 3 months. A majority of those given ...

Please provide your email address to receive an email when new articles are posted on . Adolescents with migraine were given lidocaine cream, lidocaine injections and saline injections. At 24 hours, ...

The University of Miami Miller School of Medicine is offering a new treatment for migraines involving IV injections administered to a patient over several days, according to a Miami Herald report. The ...

It began as an odd observation among plastic surgery patients, and ended up as an FDA approved drug — on Friday, the agency green-lighted the use of Botox, a popular wrinkle-reducing procedure, to ...

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...

Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...

“When I got here in Muscatine, we were looking at needs in the community and discovered that there is a real lack of access to neurology and migraine management in the area, so given that I had some ...

Shares of Amneal Pharmaceuticals, Inc. (AMRX) traded marginally higher on Thursday morning after the U.S. Food and Drug Administration (FDA) approved its self-administrable Brekiya injection for ...

Prof Fayyaz Ahmed, who has written a new book, believes migraines will not be cured in his lifetime.